Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Bayer Stock News

BAYRYOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Q4 2024 Earnings were released on Wed Mar 5th, before the market open

Bayer (BAYRY) Forecast

News

Earnings Bayer (BAYRY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Bayer Stock News | OTC:BAYRY | Benzinga

Get the latest news on Bayer stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Bayer performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, March 05, 2025

Bayer CEO: 2025 Will Be 'Most Difficult' Year In Turnaround Plan, Expects Improved Performance From 2026 Onwards
Vandana Singh
Bayer Sees FY2025 Adj EPS $4.80-$5.33 vs $4.6...
Benzinga Newsdesk
Bayer Q4 Adj $0.28 Misses $1.00 Estimate, Sal...
Benzinga Newsdesk

Tuesday, December 17, 2024

Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Vandana Singh

Monday, November 25, 2024

FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Vandana Singh

Tuesday, November 19, 2024

BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
Vandana Singh
Cytokinetics And Bayer Partner For Exclusive ...
Benzinga Newsdesk

Tuesday, November 12, 2024

Bayer Confirms Its 2024 Guidance, Sales Of €4...
Benzinga Newsdesk
Bayer Q3 2024 Adj. EPADS $0.07 Misses $0.17 E...
Benzinga Newsdesk

Tuesday, October 15, 2024

Bayer Seeks European Approval For Its Menopause Drug
Vandana Singh

Monday, October 14, 2024

Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide
Vandana Singh

Tuesday, September 24, 2024

Johnson & Johnson Files for Bankruptcy Over Talc Lawsuits for the Third Time
Zacks

Monday, September 16, 2024

Bayer Targets Expanded Use Approval For Prostate Cancer Drug, Reveals Encouraging Data From Pivotal Study
Vandana Singh

Tuesday, September 10, 2024

Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
Vandana Singh

Friday, August 30, 2024

Why Is BridgeBio Pharma Stock Trading Higher On Friday?
Vandana Singh

Tuesday, August 27, 2024

Regeneron's Bispecific Antibody Obtains EC Nod for Lymphoma
Zacks

Thursday, August 01, 2024

Regeneron Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
Zacks

Thursday, July 25, 2024

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Vandana Singh

Wednesday, June 05, 2024

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Vandana Singh

Monday, May 27, 2024

European Equities Close Higher As Traders Bank On Imminent ECB Rate Cut: What's Driving Markets Monday?
Piero Cingari

Friday, May 24, 2024

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Vandana Singh

Friday, May 17, 2024

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Vandana Singh

Thursday, May 16, 2024

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Upwallstreet

Friday, May 10, 2024

From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing - Stocks To Watch
Vandana Singh

Thursday, May 02, 2024

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Vandana Singh

Wednesday, April 10, 2024

Alphabet, Nasdaq, Spotify, Teck Resources And A Major Financial Stock On CNBC's 'Final Trades'
Avi Kapoor

Tuesday, April 09, 2024

Google Partners With European Conglomerate Bayer For New AI-Powered Solutions For Radiologists
Vandana Singh

Friday, April 05, 2024

Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
Piero Cingari

Tuesday, March 19, 2024

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Vandana Singh

Thursday, March 14, 2024

German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Vandana Singh

Wednesday, March 06, 2024

Boundless Bio Files For IPO; Applies To List ...
Benzinga Newsdesk

Tuesday, March 05, 2024

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Vandana Singh

Monday, March 04, 2024

What's Going On With BridgeBio Pharma Stock On Monday?
Vandana Singh
BridgeBio Pharma And Bayer Announce European ...
Benzinga Newsdesk

Tuesday, January 30, 2024

Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Vandana Singh

Monday, January 29, 2024

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Vandana Singh

Thursday, January 11, 2024

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Vandana Singh

Monday, January 08, 2024

Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Vandana Singh

Thursday, January 04, 2024

Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Vandana Singh

Wednesday, January 03, 2024

Top Stocks, Sectors Loved By Congress Members Who Traded In 2023: Apple, NVIDIA, Microsoft, Ford And More Stocks To Watch In 2024
Chris Katje

Tuesday, December 26, 2023

Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Vandana Singh

Tuesday, December 19, 2023

ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Surbhi Jain

Wednesday, December 06, 2023

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Vandana Singh

Monday, December 04, 2023

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Vandana Singh

Tuesday, November 28, 2023

PFAS's Forever Problem: Ohio Lawsuit Against Chemical Companies Fizzles Out
Natan Ponieman

Friday, November 24, 2023

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Vandana Singh

Monday, November 20, 2023

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Vandana Singh
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Vandana Singh

Friday, November 17, 2023

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Vandana Singh

Tuesday, November 14, 2023

AI Is Pharma's Newest Power Tool For Enhancing Clinical Trials
Upwallstreet

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved